ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,971 | -15.8% | 56,692 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $366,876 | -22.8% | 54,676 | +1.6% | 0.00% | -33.3% |
| Q1 2023 | $475,142 | +17.9% | 53,810 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $402,926 | +6.9% | 52,739 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $377,000 | -10.7% | 52,930 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $422,000 | +1463.0% | 52,183 | +2555.6% | 0.00% | – |
| Q1 2022 | $27,000 | -50.9% | 1,965 | -0.1% | 0.00% | – |
| Q4 2021 | $55,000 | -20.3% | 1,967 | -3.4% | 0.00% | – |
| Q3 2021 | $69,000 | -23.3% | 2,036 | -7.3% | 0.00% | – |
| Q2 2021 | $90,000 | +30.4% | 2,197 | +28.6% | 0.00% | – |
| Q1 2021 | $69,000 | -38.9% | 1,709 | -10.7% | 0.00% | – |
| Q4 2020 | $113,000 | +16.5% | 1,914 | -4.0% | 0.00% | – |
| Q3 2020 | $97,000 | +3.2% | 1,994 | +2.5% | 0.00% | – |
| Q2 2020 | $94,000 | +141.0% | 1,946 | +39.8% | 0.00% | – |
| Q1 2020 | $39,000 | +290.0% | 1,392 | +300.0% | 0.00% | – |
| Q4 2019 | $10,000 | -9.1% | 348 | -3.9% | 0.00% | – |
| Q3 2019 | $11,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |